【科兴控股:2025—2026年流感季流感疫苗率先获批上市】金十数据4月17日讯,4月16日,北京科兴控股(集团)有限公司旗下北京科兴生物制品有限公司生产的2025—2026年流感季流感疫苗在国内率先获得中国食品药品检定研究院批签发证明,公司将全力做好疫苗的生产和供应保障,助力2025—2026年北半球流感季流感防控。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.